Blog Network

Upcoming Events

About

The Future of BioPharma blog provides timely coverage of news that directly impacts the business strategies of the biotech, pharmaceutical and medical device industries. In addition to news coverage, the Future of BioPharma blog features live event coverage from IIR's Biopharmaceutical and Healthcare division.

Favorites

Friday, May 3, 2013

Pandemic preparedness is a regulatory and industry effort. Today we feature two of the sessions at Vaccines Development and Production Summit. You can hear from the latest U.S. Department of Health and Human Services efforts from Keynote Presenter Robert C. Huebner, Ph.D., Acting Director, Influenza Division, HHS/ASPR/BARDA. We'll also be joined by Manon M.J. Cox, President and CEO, Protein Sciences Corporation, who developed the the novel technology Flublok. It was also the worlds’ first recombinant, highly purified, egg-free influenza vaccine and it successively navigated the regulatory pathway of the FDA.

Development of New Influenza Vaccines for Pandemic Preparedness and the Future

Featured Speaker: Robert C. Huebner, Ph.D., Acting Director Influenza Division, HHS/ASPR/BARDAAbout the presentation: Since 2004, BARDA has supported the nation’s pandemic preparedness and the technology use for seasonal and pandemic influenza vaccine production. This talk reviews the progress of the current BARDA programs and discusses future efforts to meet the nation’s needs for seasonal and pandemic influenza vaccines.

Featured Speaker: Manon M.J. Cox, President and CEO, Protein Sciences Corporation About the presentation:This presentation explores the novel manufacturing technology and regulatory pathway of Flublok, which the FDA regards as a technological advance in the manufacturing of an influenza vaccine. This keynote examines the departure from using the virus and eggs in production and how the process allows for the rapid production of large quantities of the influenza virus protein, hemagglutinin (HA), using a baculovirus expression system.

Share this article with your social network, just click below to share now!